WuXi AppTec took part in the cancer test developer's latest round through WuXi NextCode and 6 Dimensions Capital, taking its total funding to more than $1.6bn.

The corporate is one of three investors that have supplied $10m for the fund, which will focus on cardiovascular, stroke and diabetes care.

Legend Star has contributed to a $37.5m round for HifiBio, which is developing antibody treatments for cancer and autoimmune diseases.

The $157m fund will be the Legend Holdings-backed venture firm's second RMB-denominated healthcare fund and its third overall.

The round, which takes Indee's equity total to $3.9m, featured Main Sequence Ventures.

Cardeation Capital has raised $10m each from UPMC, Royal Philips and American Heart Association to make investments aimed at fighting cardiovascular disease and stroke.

6 Dimensions Capital led a round for the miniprotein drug developer, founded by Harvard researcher Gregory Verdine.

Tufts University has opened a 15,000 square-foot biotech incubator managed by BioLabs with enough room for 100 scientists and entrepreneurs.